FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 64 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $279,000 | -76.0% | 56,378 | -46.2% | 0.03% | -72.2% |
| Q4 2016 | $1,164,000 | +2.1% | 104,880 | -14.8% | 0.10% | -11.0% |
| Q3 2016 | $1,140,000 | +23.4% | 123,123 | -15.4% | 0.11% | -14.2% |
| Q2 2016 | $924,000 | +25.5% | 145,508 | +29.0% | 0.13% | +25.7% |
| Q1 2016 | $736,000 | -16.7% | 112,811 | +3.5% | 0.10% | -9.8% |
| Q4 2015 | $884,000 | +31.4% | 109,011 | +18.7% | 0.11% | +5.7% |
| Q3 2015 | $673,000 | -24.5% | 91,811 | +5.6% | 0.11% | -27.4% |
| Q2 2015 | $891,000 | +47.0% | 86,909 | +32.6% | 0.15% | +87.2% |
| Q1 2015 | $606,000 | – | 65,559 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |